Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 416235, 8 pages
http://dx.doi.org/10.1155/2015/416235
Review Article

Pulmonary Protection Strategies in Cardiac Surgery: Are We Making Any Progress?

1Bristol Heart Institute, Bristol Royal Infirmary, Upper Maudlin Street, Bristol BS2 8HW, UK
2Cardiac Surgery, National Heart and Lung Institute, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0HS, UK

Received 5 February 2015; Accepted 12 March 2015

Academic Editor: Gianfranco Pintus

Copyright © 2015 Emad Al Jaaly et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ascione, C. T. Lloyd, M. J. Underwood, A. A. Lotto, A. A. Pitsis, and G. D. Angelini, “Economic outcome of off-pump coronary artery bypass surgery: a prospective randomized study,” The Annals of Thoracic Surgery, vol. 68, no. 6, pp. 2237–2242, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. G. E. Hill, “Cardiopulmonary bypass-induced inflammation: is it important?” Journal of Cardiothoracic and Vascular Anesthesia, vol. 12, no. 2, pp. 21–25, 1998. View at Google Scholar · View at Scopus
  3. E. E. Apostolakis, E. N. Koletsis, N. G. Baikoussis, S. N. Siminelakis, and G. S. Papadopoulos, “Strategies to prevent intraoperative lung injury during cardiopulmonary bypass,” Journal of Cardiothoracic Surgery, vol. 5, no. 1, article 1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Ali-Hassan-Sayegh, S. J. Mirhosseini, V. Vahabzadeh, and N. Ghaffari, “Should the integrity of the pleura during internal mammary artery harvesting be preserved?” Interactive CardioVascular and Thoracic Surgery, vol. 19, no. 5, pp. 838–847, 2014. View at Publisher · View at Google Scholar
  5. M. Ragnarsdóttir, Á. Kristjánsdóttir, I. Ingvarsdóttir, P. Hannesson, B. Torfason, and L. P. Cahalin, “Short-term changes in pulmonary function and respiratory movements after cardiac surgery via median sternotomy,” Scandinavian Cardiovascular Journal, vol. 38, no. 1, pp. 46–52, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. T. J. Locke, T. L. Griffiths, H. Mould, and G. J. Gibson, “Rib cage mechanics after median sternotomy,” Thorax, vol. 45, no. 6, pp. 465–468, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Baufreton, J.-J. Corbeau, and F. Pinaud, “Inflammatory response and haematological disorders in cardiac surgery: toward a more physiological cardiopulmonary bypass,” Annales Francaises d'Anesthesie et de Reanimation, vol. 25, no. 5, pp. 510–520, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. K. Kirklin, S. Westaby, E. H. Blackstone, J. W. Kirklin, D. E. Chenoweth, and A. D. Pacifico, “Complement and the damaging effects of cardiopulmonary bypass,” Journal of Thoracic and Cardiovascular Surgery, vol. 86, no. 6, pp. 845–857, 1983. View at Google Scholar · View at Scopus
  9. M.-S. Suleiman, K. Zacharowski, and G. D. Angelini, “Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics,” British Journal of Pharmacology, vol. 153, no. 1, pp. 21–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Zakkar, G. Guida, M. S. Suleiman, and G. D. Angelini, “Cardiopulmonary bypass and oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 189863, 8 pages, 2015. View at Publisher · View at Google Scholar
  11. N. Fiotti, C. Giansante, E. Ponte et al., “Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease,” Atherosclerosis, vol. 145, no. 1, pp. 51–60, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Tesfamariam and A. F. DeFelice, “Endothelial injury in the initiation and progression of vascular disorders,” Vascular Pharmacology, vol. 46, no. 4, pp. 229–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. K. van der Heiden, S. Cuhlmann, L. A. Luong, M. Zakkar, and P. C. Evans, “Role of nuclear factor κB in cardiovascular health and disease,” Clinical Science, vol. 118, no. 10, pp. 593–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. E. M. Boyle Jr., S. T. Lille, E. Allaire, A. W. Clowes, and E. D. Verrier, “Endothelial cell injury in cardiovascular surgery: atherosclerosis,” The Annals of Thoracic Surgery, vol. 63, no. 3, pp. 885–894, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Gao, B. Xie, C. Gu, H. Li, F. Zhang, and Y. Yu, “Targeting the proinflammatory cytokine tumor necrosis factor-α to alleviate cardiopulmonary bypass-induced lung injury (review),” Molecular Medicine Reports, vol. 11, pp. 2373–2378, 2014. View at Publisher · View at Google Scholar
  16. S. R. Khan, “Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis,” Translational Andrology and Urology, vol. 3, pp. 256–276, 2014. View at Google Scholar
  17. L. Rochette, J. Lorin, M. Zeller et al., “Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?” Pharmacology and Therapeutics, vol. 140, no. 3, pp. 239–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. W. A. Muller, “Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response,” Trends in Immunology, vol. 24, no. 6, pp. 327–334, 2003. View at Google Scholar · View at Scopus
  19. R. P. McEver, “Selectins,” Current Opinion in Immunology, vol. 6, no. 1, pp. 75–84, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. R. P. McEver, “Selectins: lectins that initiate cell adhesion under flow,” Current Opinion in Cell Biology, vol. 14, no. 5, pp. 581–586, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. M. L. Dustin, R. Rothlein, A. K. Bhan, C. A. Dinarello, and T. A. Springer, “Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1),” The Journal of Immunology, vol. 137, pp. 245–254, 1986, The Journal of Immunology (Baltimore, Md, 1950), vol. 186, pp. 5024–5033, 2011. View at Google Scholar
  22. C. S. H. Ng, S. Wan, A. P. C. Yim, and A. A. Arifi, “Pulmonary dysfunction after cardiac surgery,” Chest, vol. 121, no. 4, pp. 1269–1277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Magnusson, V. Zemgulis, S. Wicky, H. Tydén, S. Thelin, and G. Hedenstierna, “Atelectasis is a major cause of hypoxemia and shunt after cardiopulmonary bypass: An experimental study,” Anesthesiology, vol. 87, no. 5, pp. 1153–1163, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Verheij, A. van Lingen, P. G. H. M. Raijmakers et al., “Pulmonary abnormalities after cardiac surgery are better explained by atelectasis than by increased permeability oedema,” Acta Anaesthesiologica Scandinavica, vol. 49, no. 9, pp. 1302–1310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Li, X. Wu, F. Yan et al., “Effects of pulmonary artery perfusion with urinary trypsin inhibitor as a lung protective strategy under hypothermic low-flow cardiopulmonary bypass in an infant piglet model,” Perfusion, vol. 29, no. 5, pp. 434–442, 2014. View at Publisher · View at Google Scholar
  26. M. E. Callister, A. Burke-Gaffney, G. J. Quinlan et al., “Extracellular thioredoxin levels are increased in patients with acute lung injury,” Thorax, vol. 61, no. 6, pp. 521–527, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. N. J. Lamb, J. M. C. Gutteridge, C. Baker, T. W. Evans, and G. J. Quinlan, “Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination,” Critical Care Medicine, vol. 27, no. 9, pp. 1738–1744, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Weissman, “Pulmonary complications after cardiac surgery,” Seminars in Cardiothoracic and Vascular Anesthesia, vol. 8, no. 3, pp. 185–211, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Goodyear-Bruch and J. D. Pierce, “Oxidative stress in critically ill patients,” The American Journal of Critical Care, vol. 11, no. 6, pp. 543–551, 2002. View at Google Scholar · View at Scopus
  30. M. F. Vidal Melo, G. Musch, and D. W. Kaczka, “Pulmonary pathophysiology and lung mechanics in anesthesiology: a case-based overview,” Anesthesiology Clinics, vol. 30, no. 4, pp. 759–784, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Relevy, A. Koshkaryev, N. Manny, S. Yedgar, and G. Barshtein, “Blood banking-induced alteration of red blood cell flow properties,” Transfusion, vol. 48, no. 1, pp. 136–146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Karkouti, “Transfusion and risk of acute kidney injury in cardiac surgery,” British Journal of Anaesthesia, vol. 109, supplement 1, pp. i29–i38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Bitargil, C. Arslan, H. Başbuğ, H. Göçer, Y. Günerhan, and Y. Bekov, “Transfusion-related acute lung injury following coronary artery bypass graft surgery,” Perfusion, 2015. View at Publisher · View at Google Scholar
  34. R. Dasararaju and M. B. Marques, “Adverse effects of transfusion,” Cancer Control, vol. 22, pp. 16–25, 2015. View at Google Scholar
  35. J. Raud, “Vasodilatation and inhibition of mediator release represent two distinct mechanisms for prostaglandin modulation of acute mast cell-dependent inflammation,” The British Journal of Pharmacology, vol. 99, no. 3, pp. 449–454, 1990. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Raslan and K. M. Naseem, “Compartmentalisation of cAMP-dependent signalling in blood platelets: the role of lipid rafts and actin polymerisation,” Platelets, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  37. A. H. Sprague and R. A. Khalil, “Inflammatory cytokines in vascular dysfunction and vascular disease,” Biochemical Pharmacology, vol. 78, no. 6, pp. 539–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-I. Kawabe, F. Ushikubi, and N. Hasebe, “Prostacyclin in vascular diseases—recent insights and future perspectives,” Circulation Journal, vol. 74, no. 5, pp. 836–843, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Kemming, O. Habler, M. Kleen, H. Kisch-Wedel, M. Welte, and B. Zwissler, “Searching the ideal inhaled vasodilator: from nitric oxide to prostacyclin,” European Surgical Research, vol. 34, no. 1-2, pp. 196–202, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Haché, A. Denault, S. Bélisle et al., “Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery,” Journal of Thoracic and Cardiovascular Surgery, vol. 125, no. 3, pp. 642–649, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. C. J. de Wet, D. G. Affleck, E. Jacobsohn et al., “Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery,” The Journal of Thoracic and Cardiovascular Surgery, vol. 127, no. 4, pp. 1058–1067, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Rex, G. Schaelte, S. Metzelder et al., “Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial,” Acta Anaesthesiologica Scandinavica, vol. 52, no. 1, pp. 65–72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Fortier, R. G. DeMaria, Y. Lamarche et al., “Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels,” Journal of Thoracic and Cardiovascular Surgery, vol. 128, no. 1, pp. 109–116, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. S. M. Lowson, A. Doctor, B. K. Walsh, and P. A. Doorley, “Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery,” Critical Care Medicine, vol. 30, no. 12, pp. 2762–2764, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. J. M. Porter, B. S. Cutler, B. Y. Lee et al., “Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients,” American Heart Journal, vol. 104, no. 1, pp. 66–72, 1982. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Michetti, R. Coimbra, D. B. Hoyt, W. Loomis, W. Junger, and P. Wolf, “Pentoxifylline reduces acute lung injury in chronic endotoxemia,” Journal of Surgical Research, vol. 115, no. 1, pp. 92–99, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Kreth, C. Ledderose, B. Luchting, F. Weis, and M. Thiel, “Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways,” Shock, vol. 34, no. 1, pp. 10–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. F. M. Konrad, G. Neudeck, I. Vollmer, K. C. Ngamsri, M. Thiel, and J. Reutershan, “Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A2A dependent,” The FASEB Journal, vol. 27, no. 9, pp. 3524–3535, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. V. H. Kumar, D. D. Swartz, N. Rashid et al., “Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension,” Journal of Applied Physiology, vol. 109, no. 3, pp. 677–684, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. Å. Haraldsson, N. Kieler-Jensen, and S.-E. Ricksten, “The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension,” Anesthesia & Analgesia, vol. 93, no. 6, pp. 1439–1445, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Song and M.-H. Zou, “Redox regulation of endothelial cell fate,” Cellular and Molecular Life Sciences, vol. 71, no. 17, pp. 3219–3239, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Guery, R. Neviere, N. Viget et al., “Inhaled NO preadministration modulates local and remote ischemia- reperfusion organ injury in a rat model,” Journal of Applied Physiology, vol. 87, no. 1, pp. 47–53, 1999. View at Google Scholar · View at Scopus
  53. E. A. Bacha, H. Sellak, S. Murakami et al., “Inhaled nitric oxide attenuates reperfusion injury in non-heartbeating-donor lung transplantation,” Transplantation, vol. 63, no. 10, pp. 1380–1386, 1997. View at Publisher · View at Google Scholar · View at Scopus
  54. V. Brovkovych, X.-P. Gao, E. Ong et al., “Augmented inducible nitric oxide synthase expression and increased NO production reduce sepsis-induced lung injury and mortality in myeloperoxidase-null mice,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 295, no. 1, pp. L96–L103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. K. D. Bloch, F. Ichinose, J. D. Roberts Jr., and W. M. Zapol, “Inhaled NO as a therapeutic agent,” Cardiovascular Research, vol. 75, no. 2, pp. 339–348, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. L. C. Price, S. J. Wort, S. J. Finney, P. S. Marino, and S. J. Brett, “Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review,” Critical Care, vol. 14, no. 5, article R169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Ichinose, J. D. Roberts Jr., and W. M. Zapol, “Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential,” Circulation, vol. 109, no. 25, pp. 3106–3111, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Naka, D. K. Roy, A. J. Smerling et al., “Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate,” The Journal of Thoracic and Cardiovascular Surgery, vol. 110, no. 5, pp. 1434–1441, 1995. View at Publisher · View at Google Scholar · View at Scopus
  59. M. J. Eppinger, P. A. Ward, M. L. Jones, S. F. Bolling, and G. M. Deeb, “Disparate effects of nitric oxide on lung ischemia-reperfusion injury,” The Annals of Thoracic Surgery, vol. 60, no. 5, pp. 1169–1176, 1995. View at Publisher · View at Google Scholar · View at Scopus
  60. G. E. Hill, R. Pohorecki, A. Alonso, S. I. Rennard, and R. A. Robbins, “Aprotinin reduces interleukin-8 production and lung neutrophil accumulation after cardiopulmonary bypass,” Anesthesia and Analgesia, vol. 83, no. 4, pp. 696–700, 1996. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Erdogan, S. Kalaycioglu, and E. Iriz, “Protective effect of aprotinin against lung damage in patients undergoing CABG surgery,” Acta Cardiologica, vol. 60, no. 4, pp. 367–372, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Viviano, R. Kanagasabay, and M. Zakkar, “Is perioperative corticosteroid administration associated with a reduced incidence of postoperative atrial fibrillation in adult cardiac surgery?” Interactive Cardiovascular and Thoracic Surgery, vol. 18, no. 2, pp. 225–229, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Zakkar and R. Kanagasabay, “Glucocorticoids in adult cardiac surgery; old drugs revisited,” Perfusion, vol. 28, no. 5, pp. 395–402, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. P. W. Weerwind, J. G. Maessen, L. J. H. van Tits et al., “Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass,” The Journal of Thoracic and Cardiovascular Surgery, vol. 110, no. 6, pp. 1633–1641, 1995. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Bozdayi, J. Borowiec, L. Nilsson, P. Venge, S. Thelin, and H. E. Hansson, “Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery,” Artificial Organs, vol. 20, no. 9, pp. 1008–1016, 1996. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Fukutomi, S. Kobayashi, K. Niwaya, Y. Hamada, and S. Kitamura, “Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment,” Artificial Organs, vol. 20, no. 7, pp. 767–776, 1996. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Wan, J.-L. Leclerc, M. Antoine, J.-M. Desmet, A. P. C. Yim, and J.-L. Vincent, “Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study,” The Annals of Thoracic Surgery, vol. 68, no. 4, pp. 1230–1235, 1999. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Ranucci, S. Cirri, D. Conti et al., “Beneficial effects of Duraflo II heparin-coated circuits on postperfusion lung dysfunction,” The Annals of Thoracic Surgery, vol. 61, no. 1, pp. 76–81, 1996. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Bando, R. Pillai, D. E. Cameron et al., “Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass,” The Journal of Thoracic and Cardiovascular Surgery, vol. 99, no. 5, pp. 873–877, 1990. View at Google Scholar · View at Scopus
  70. J. H. Lemmer Jr., E. W. Dilling, J. R. Morton et al., “Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens,” Annals of Thoracic Surgery, vol. 62, no. 6, pp. 1659–1668, 1996. View at Publisher · View at Google Scholar · View at Scopus
  71. S. V. Sheppard, R. V. Gibbs, and D. C. Smith, “Does leucocyte depletion during cardiopulmonary bypass improve oxygenation indices in patients with mild lung dysfunction?” British Journal of Anaesthesia, vol. 93, no. 6, pp. 789–792, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Alexiou, S. Sheppard, A. Tang et al., “Leukocytes-depleting filters preferentially remove activated leukocytes and reduce the expression of surface adhesion molecules during the simulated extracorporeal circulation of human blood,” ASAIO Journal, vol. 52, no. 4, pp. 438–444, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Zakkar, G. Guida, and G. D. Angelini, “Modified ultrafiltration in adult patients undergoing cardiac surgery,” Interactive CardioVascular and Thoracic Surgery, vol. 20, no. 3, pp. 415–421, 2015. View at Publisher · View at Google Scholar
  74. R. H. Habib, A. Zacharias, T. A. Schwann et al., “Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome,” Critical Care Medicine, vol. 33, no. 8, pp. 1749–1756, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. O. M. Theusinger, C. Felix, and D. R. Spahn, “Strategies to reduce the use of blood products: a European perspective,” Current Opinion in Anaesthesiology, vol. 25, no. 1, pp. 59–65, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. X. Yewei, D. Liya, Z. Jinghao, Z. Rufang, and S. Li, “Study of the mechanism of pulmonary protection strategy on pulmonary injury with deep hypothermia low flow,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 7, pp. 879–885, 2013. View at Google Scholar · View at Scopus
  77. M. Siepe, U. Goebel, A. Mecklenburg et al., “Pulsatile pulmonary perfusion during cardiopulmonary bypass reduces the pulmonary inflammatory response,” Annals of Thoracic Surgery, vol. 86, no. 1, pp. 115–122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Santini, F. Onorati, M. Telesca et al., “Selective pulmonary pulsatile perfusion with oxygenated blood during cardiopulmonary bypass attenuates lung tissue inflammation but does not affect circulating cytokine levels,” European Journal of Cardio-Thoracic Surgery, vol. 42, no. 6, Article ID ezs199, pp. 942–950, 2012. View at Google Scholar · View at Scopus
  79. F. Santini, F. Onorati, M. Telesca et al., “Pulsatile pulmonary perfusion with oxygenated blood ameliorates pulmonary hemodynamic and respiratory indices in low-risk coronary artery bypass patients,” European Journal of Cardio-Thoracic Surgery, vol. 40, no. 4, pp. 794–803, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. F. I. B. Macedo, A. L. Panos, F. M. Andreopoulos, T. A. Salerno, and S. M. Pham, “Lung perfusion and ventilation during implantation of left ventricular assist device as a strategy to avoid postoperative pulmonary complications and right ventricular failure,” Interactive CardioVascular and Thoracic Surgery, vol. 17, no. 5, pp. 764–766, 2013. View at Publisher · View at Google Scholar
  81. A.-H. Kiessling, F. W. Guo, Y. Gökdemir et al., “The influence of selective pulmonary perfusion on the inflammatory response and clinical outcome of patients with chronic obstructive pulmonary disease undergoing cardiopulmonary bypass,” Interactive Cardiovascular and Thoracic Surgery, vol. 18, no. 6, pp. 732–739, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. W. B. Gerritsen, W.-J. P. van Boven, D. S. Boss, F. J. Haas, E. P. van Dongen, and L. P. Aarts, “Malondialdehyde in plasma, a biomarker of global oxidative stress during mini-CABG compared to on- and off-pump CABG surgery: a pilot study,” Interactive Cardiovascular and Thoracic Surgery, vol. 5, no. 1, pp. 27–31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. W.-J. van Boven, W. B. Gerritsen, F. G. Waanders, F. J. Haas, and L. P. Aarts, “Mini extracorporeal circuit for coronary artery bypass grafting: initial clinical and biochemical results: a comparison with conventional and off-pump coronary artery bypass grafts concerning global oxidative stress and alveolar function,” Perfusion, vol. 19, no. 4, pp. 239–246, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. H. A. Vohra, R. Whistance, A. Modi, and S. K. Ohri, “The inflammatory response to miniaturised extracorporeal circulation: a review of the literature,” Mediators of Inflammation, vol. 2009, Article ID 707042, 7 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Zeitani, F. Buccisano, S. Nardella et al., “Mini-extracorporeal circulation minimizes coagulation abnormalities and ameliorates pulmonary outcome in coronary artery bypass grafting surgery,” Perfusion, vol. 28, no. 4, pp. 298–305, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Loeckinger, A. Kleinsasser, K. H. Lindner, J. Margreiter, C. Keller, and C. Hoermann, “Continuous positive airway pressure at 10 cm H2O during cardiopulmonary bypass improves postoperative gas exchange,” Anesthesia and Analgesia, vol. 91, no. 3, pp. 522–527, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. H. Imura, M. Caputo, K. Lim et al., “Pulmonary injury after cardiopulmonary bypass: beneficial effects of low-frequency mechanical ventilation,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, no. 6, pp. 1530–1537, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Gagnon, D. Laporta, F. Béïque, Y. Langlois, and J.-F. Morin, “Clinical relevance of ventilation during cardiopulmonary bypass in the prevention of postoperative lung dysfunction,” Perfusion, vol. 25, no. 4, pp. 205–210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. J.-U. Schreiber, M. D. Lancé, M. de Korte, T. Artmann, I. Aleksic, and P. Kranke, “The effect of different lung-protective strategies in patients during cardiopulmonary bypass: a meta-analysis and semiquantitative review of randomized trials,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 26, no. 3, pp. 448–454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. A. J. Berson, J. M. Smith, S. E. Woods, K. A. Hasselfeld, and L. F. Hiratzka, “Off-pump versus on-pump coronary artery bypass surgery: does the pump influence outcome?” Journal of the American College of Surgeons, vol. 199, no. 1, pp. 102–108, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. G. D. Angelini, F. C. Taylor, B. C. Reeves, and R. Ascione, “Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials,” The Lancet, vol. 359, no. 9313, pp. 1194–1199, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Syed, H. Fawzy, A. Farag, and A. Nemlander, “Comparison of pulmonary gas exchange in OPCAB versus conventional CABG,” Heart Lung and Circulation, vol. 13, no. 2, pp. 168–172, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. E. H. J. Hulzebos, P. J. M. Helders, N. J. Favié, R. A. de Bie, A. B. de La Riviere, and N. L. U. van Meeteren, “Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial,” Journal of the American Medical Association, vol. 296, no. 15, pp. 1851–1857, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. A. H. Herdy, P. L. B. Marcchi, A. Vila et al., “Pre- and postoperative cardiopulmonary rehabilitation in hospitalized patients undergoing coronary artery bypass surgery a randomized controlled trial,” American Journal of Physical Medicine & Rehabilitation, vol. 87, no. 9, pp. 714–719, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. P. Agostini and S. Singh, “Incentive spirometry following thoracic surgery: what should we be doing?” Physiotherapy, vol. 95, no. 2, pp. 76–82, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. C. Urell, M. Emtner, H. Hedenström, A. Tenling, M. Breidenskog, and E. Westerdahl, “Deep breathing exercises with positive expiratory pressure at a higher rate improve oxygenation in the early period after cardiac surgery—a randomised controlled trial,” European Journal of Cardio-Thoracic Surgery, vol. 40, no. 1, pp. 162–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. E. Westerdahl, B. Lindmark, T. Eriksson, Ö. Friberg, G. Hedenstierna, and A. Tenling, “Deep-breathing exercises reduce atelectasis and improve pulmonary function after coronary artery bypass surgery,” Chest, vol. 128, no. 5, pp. 3482–3488, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. C. R. F. Carvalho, D. M. Paisani, and A. C. Lunardi, “Incentive spirometry in major surgeries: a systematic review,” Revista Brasileira de Fisioterapia, vol. 15, no. 5, pp. 343–350, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. F. Guarracino, L. Cabrini, R. Baldassarri et al., “Non-invasive ventilation-aided transoesophageal echocardiography in high-risk patients: a pilot study,” European Journal of Echocardiography, vol. 11, no. 6, pp. 554–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. F. Guarracino, L. Cabrini, R. Baldassarri et al., “Noninvasive ventilation for awake percutaneous aortic valve implantation in high-risk respiratory patients: a case series,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 25, no. 6, pp. 1109–1112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. L. Cabrini, V. P. Plumari, L. Nobile et al., “Non-invasive ventilation in cardiac surgery: a concise review,” Heart, Lung and Vessels, vol. 5, pp. 137–141, 2013. View at Google Scholar
  102. L. Denehy and S. Berney, “The use of positive pressure devices by physiotherapists,” The European Respiratory Journal, vol. 17, no. 4, pp. 821–829, 2001. View at Publisher · View at Google Scholar · View at Scopus
  103. V. Squadrone, M. Coha, E. Cerutti et al., “Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial,” Journal of the American Medical Association, vol. 293, no. 5, pp. 589–595, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. F. Pilkington, “Humidification for oxygen therapy in non-ventilated patients,” British Journal of Nursing, vol. 13, no. 2, pp. 111–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. C. Hormann, M. Baum, C. Putensen, N. J. Mutz, and H. Benzer, “Biphasic positive airway pressure (BIPAP)—a new mode of ventilatory support,” European Journal of Anaesthesiology, vol. 11, no. 1, pp. 37–42, 1994. View at Google Scholar · View at Scopus
  106. S. Baudouin, S. Blumenthal, B. Cooper et al., “Non-invasive ventilation in acute respiratory failure: British thoracic society standards of care committee,” Thorax, vol. 57, no. 3, pp. 192–211, 2002. View at Publisher · View at Google Scholar · View at Scopus
  107. S. Stoltzfus, “The role of noninvasive ventilation: CPAP and BiPAP in the treatment of congestive heart failure,” Dimensions of Critical Care Nursing, vol. 25, no. 2, pp. 66–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. C. M. Roberts, J. L. Brown, A. K. Reinhardt et al., “Non-invasive ventilation in chronic obstructive pulmonary disease: management of acute type 2 respiratory failure,” Clinical Medicine, vol. 8, no. 5, pp. 517–521, 2008. View at Google Scholar · View at Scopus
  109. C. R. Lopes, C. M. Brandão, E. Nozawa, and J. O. Auler Jr., “Benefits of non-invasive ventilation after extubation in the postoperative period of heart surgery,” Revista Brasileira de Cirurgia Cardiovascular, vol. 23, no. 3, pp. 344–350, 2008. View at Google Scholar · View at Scopus
  110. M. García-Delgado, I. Navarrete, M. J. García-Palma, and M. Colmenero, “Postoperative respiratory failure after cardiac surgery: use of noninvasive ventilation,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 26, no. 3, pp. 443–447, 2012. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Kilic, N. Yapıci, Y. Bıcer, T. Corub, and Z. Aykac, “Early extubation and weaning with bilevel positive airway pressure ventilation after cardiac surgery (weaning with BiPAP ventilation after cardiac surgery),” Southern African Journal of Anaesthesia and Analgesia, vol. 14, no. 5, pp. 25–31, 2008. View at Google Scholar · View at Scopus
  112. E. Al Jaaly, F. Fiorentino, B. C. Reeves et al., “Effect of adding postoperative noninvasive ventilation to usual care to prevent pulmonary complications in patients undergoing coronary artery bypass grafting: a randomized controlled trial,” The Journal of Thoracic and Cardiovascular Surgery, vol. 146, no. 4, pp. 912–918, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. P. Pasquina, P. Merlani, J. M. Granier, and B. Ricou, “Continuous positive airway pressure versus noninvasive pressure support ventilation to treat atelectasis after cardiac surgery,” Anesthesia and Analgesia, vol. 99, no. 4, pp. 1001–1008, 2004. View at Publisher · View at Google Scholar · View at Scopus